CV Sciences, Inc.
For the period ended Mar 27, 2025. Filed Jun 4, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Mar 27, 2025 · Filed Jun 4, 2026
Contents
Proposal 2 - Reverse Stock Split
The Company's stockholders did not approve the Company's proposal to amend its Certificate of Incorporation, as amended to effect, at the discretion of the Board of Directors, a reverse stock split of all outstanding shares of common stock at a ratio of not less than 1-for-10 and not greater than 1-for-800, such ratio to be determined by the Board of Directors at any time before May 30, 2029, without further approval or authorization from its stockholders, as set forth below:
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE |
|---|---|---|---|
| 48,496,747 | 59,628,926 | 8,109,111 | - |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.